Clinical Trials
5 trialsNCT00877656 2024-03-18
HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
Emergent BioSolutions
Phase 2/3 Completed
NCT00071071 2023-05-18
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.
Genmab
Phase 2 Completed
NCT00071084 2023-04-28
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.
Genmab
Phase 2 Completed
NCT01160445 2015-10-28
Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00127881 2012-07-26
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Emergent Product Development Seattle LLC
Phase 3 Terminated